Skip to content
Dobbs v. Jackson has had a ripple effect across healthcare—from increasing the danger of medical management of miscarriages and risk of maternal mortality, to […]
How Dobbs v. Jackson is affecting vaccine innovation Read More »
“The pandemic has exposed our country’s dependence on other countries for essential prescription drugs,” began Steve Scully, contributing editor at The Hill and moderator
COVID-19 forced us to reimagine the pharma supply chain – and that’s a good thing Read More »
National Influenza Vaccination Week is December 5–9 and serves as a reminder that it is never too late to get your flu vaccine—especially this
National Influenza Vaccination Week begins with warnings of a tough flu season Read More »
This is a tough winter for respiratory disease. Coming off of a two-year pandemic we are finding that flu season now has a few
Fight the ‘tripledemic’ with vaccines, tests, and treatment Read More »
We are about to hit the high point of the holiday season, and the Black Coalition Against COVID (BCAC) wants to ensure Black communities
Black Coalition Against COVID offers ‘plain’ talk about the holidays Read More »
Paying for healthcare in the United States has been a challenging and controversial issue for years. In a landscape managed by private insurers, Medicaid,
To ensure access for all, healthcare payment models need innovation Read More »
Rachel King was enjoying her retirement. When the COVID-19 pandemic hit, King found herself with a chance to refocus and ask herself what was
Meet Rachel King, BIO’s new interim CEO and a champion of the biotech industry Read More »
On Day 2 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit, a panel titled Implementing Legislation—Engaging CMS dug into the importance
How patient advocates can engage with CMS Read More »
With issues like Accelerated Approval, anti-vaccine legislation, and biomarkers being taken up in state capitals, these are busy times for patient advocates working at
State policies impacting access to innovative medicine, panel says Read More »
The Biotechnology Innovation Organization (BIO) kicked off Day One of its two-day Patient and Health Advocacy Summit with a welcome from Eric Dube, President
